Sunday, July 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 77 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 8741937

    Gamma glutamyl transpeptidase inhibitors and methods of use

    The Board of Regents of the University of Oklahoma · Granted Jun 3, 2014 · Expires May 29, 2034

    granted

  2. US 8741898

    Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jun 3, 2014 · Expires May 29, 2034

    granted

  3. US 8741912

    Deazapurines useful as inhibitors of Janus kinases

    Vertex Pharmaceuticals Incorporated · Granted Jun 3, 2014 · Expires May 29, 2034

    granted

  4. US 8735418

    Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases

    Rigel Pharmaceuticals, Inc. · Granted May 27, 2014 · Expires May 22, 2034

    granted

  5. US 8735593

    Aminopyridines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted May 27, 2014 · Expires May 22, 2034

    granted

  6. US 8729039

    Use of inhibitory oligonucleotides to treat autoimmune disease

    The Regents of the University of California · Granted May 20, 2014 · Expires May 15, 2034

    granted

  7. US 8729119

    Serotonin reuptake inhibitors

    Theravance, Inc. · Granted May 20, 2014 · Expires May 15, 2034

    granted

  8. US 8729053

    Nuclear factor kappa B pathway inhibitor composition and use of same

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 20, 2014 · Expires May 15, 2034

    granted

  9. US 8722889

    Azaindoles useful as inhibitors of JAK and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted May 13, 2014 · Expires May 8, 2034

    granted

  10. US 8722708

    Substituted isoindolines as aspartyl protease inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted May 13, 2014 · Expires May 8, 2034

    granted

  11. US 8722895

    Prolyl hydroxylase inhibitors and method of use

    Akebia Therapeutics, Inc. · Granted May 13, 2014 · Expires May 8, 2034

    granted

  12. US 8715649

    Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity

    The Regents of the University of Colorado, a Body Corporate · Granted May 6, 2014 · Expires May 1, 2034

    granted

  13. US 8716315

    Analogs of thalidomide as potential angiogenesis inhibitors

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 6, 2014 · Expires May 1, 2034

    granted

  14. US 8716301

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 6, 2014 · Expires May 1, 2034

    granted

  15. US 8716473

    Substituted benzotriazines and quinoxalines as inhibitors of P7OS6 kinase

    SENTINEL ONCOLOGY LIMITED · Granted May 6, 2014 · Expires May 1, 2034

    granted

  16. US 8710081

    5-lipoxygenase-activating protein (FLAP) inhibitors

    Panmira Pharmaceuticals, LLC · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  17. US 8710231

    Inhibitor of casein kinase 1delta and casein kinase 1E

    Pharmadesign, Inc. · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  18. US 8710032

    Inhibitors of the mevalonate pathway of Streptococcus pneumoniae

    Northwestern University · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  19. US 8710223

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  20. US 8703938

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  21. US 8703921

    Compositions and methods for delivering inhibitory oligonucleotides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  22. US 8697699

    Imidazopyrazine SYK inhibitors

    GILEAD CONNECTICUT, INC. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  23. US 8697698

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  24. US 8697730

    5-lipoxygenase activating protein (FLAP) inhibitor

    Panmira Pharmaceuticals, LLC · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.